Whether the efficacy and safety of dual antiplatelet therapy (DAPT) are uniform between sexes is unclear. We sought to compare clinical outcomes between short‐ (≤6 months) versus long‐term (≥1 year)… Click to show full abstract
Whether the efficacy and safety of dual antiplatelet therapy (DAPT) are uniform between sexes is unclear. We sought to compare clinical outcomes between short‐ (≤6 months) versus long‐term (≥1 year) DAPT after drug‐eluting stent (DES) placement in women and men.
               
Click one of the above tabs to view related content.